Activation of the sigma-1 receptor chaperone alleviates symptoms of Wolfram syndrome in preclinical models

MLA

Crouzier, Lucie, et al. “Activation of the Sigma-1 Receptor Chaperone Alleviates Symptoms of Wolfram Syndrome in Preclinical Models.” Science Translational Medicine, vol. 14, no. 631, Dec. 2021. EBSCOhost, https://doi.org/10.1126/scitranslmed.abh3763.

APA

Crouzier, L., Danese, A., Yasui, Y., Richard, E. M., Liévens, J.-C., Patergnani, S., Couly, S., Diez, C., Denus, M., Cubedo, N., Rossel, M., Thiry, M., Su, T.-P., Pinton, P., Maurice, T., & Delprat, B. (2021). Activation of the sigma-1 receptor chaperone alleviates symptoms of Wolfram syndrome in preclinical models. Science Translational Medicine, 14(631). https://doi.org/10.1126/scitranslmed.abh3763

Chicago

Crouzier, Lucie, Alberto Danese, Yuko Yasui, Elodie M. Richard, Jean-Charles Liévens, Simone Patergnani, Simon Couly, et al. 2021. “Activation of the Sigma-1 Receptor Chaperone Alleviates Symptoms of Wolfram Syndrome in Preclinical Models.” Science Translational Medicine 14 (631). doi:10.1126/scitranslmed.abh3763.